Skip to main content
SpringerLink
Log in

Systematic review: adverse drug events with ipragliflozin

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Liu D, et al. Adverse Drug Events Observed with the Novel Sodium/Glucose Co-Transporter 2 Inhibitor Ipragliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Studies. Advances in Therapy : 26 Aug 2020. Available from: URL: http://doi.org/10.1007/s12325-020-01471-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Systematic review: adverse drug events with ipragliflozin. Reactions Weekly 1821, 12 (2020). https://doi.org/10.1007/s40278-020-83132-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-83132-7

Search

Navigation